Generated by AI
IceCure Medical Ltd. is a commercial-stage medical device company focused on developing and marketing minimally invasive cryoablation systems for tumor treatment. Its core products use liquid nitrogen-based technology to destroy benign and cancerous tumors by freezing them, offering physicians an alternative to traditional surgical removal. The company’s portfolio includes the ProSense system and associated disposable CryoProbes, which are used in procedures across women’s health and interventional oncology. IceCure Medical also supports broader ablation applications in areas such as breast, kidney, bone, and lung cancer, with products designed for use in office-based, operating room, and imaging-guided settings. Based in Caesarea, Israel, IceCure Medical serves healthcare providers in multiple international markets and plays a niche role in expanding access to minimally invasive tumor care.
Website7 Ha’Eshel St.
Caesarea, 3079504
Israel
The latest articles about ICCM.
Summary of Nov 18's posts. Generated by AI.
Summary of Jun 24's posts. Generated by AI.
Summary of Jun 25's posts. Generated by AI.
Investors talking about ICCM also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.